Oxidative stress and ADHD
Cells are dependent on a balanced oxidative equilibrium in which neither oxidizing nor reducing substances (oxidants and antioxidants) predominate, as an excess of one side damages the cell.
Oxidative stress is an excess of reactive oxygen species (ROS) or an inadequate breakdown of ROS, which leads to damage to the cells, especially the mitochondria.1
Oxidants such as antioxidants can be absorbed through food or from the environment or produced in the body itself.
Oxidative stress can be caused by
- Food intake, medication, drugs, dentistry
- Metals
- Iron
- Cadmium
- Mercury
- Titanium dioxide2
- Copper
- increased copper causes oxidation of dopamine
- other chemicals
- Metals
- intense blue and ultraviolet light (e.g. sunburn)
- ionizing radiation (causes DNA damage and cancer)
- Air pollution, in particular
- Reactive oxygen species (ROS)
- Reactive nitrogen species
Oxidative stress can impair the dopamine system.3
- 1. Increased oxidative stress in ADHD
- 2. Oxidative stress can increase neuroinflammation
- 3. ADHD medication reduces oxidative stress
1. Increased oxidative stress in ADHD
ADHD was found to have a decreased overall antioxidant status as well as an increased total oxidative status and oxidative stress index.14
Children and adolescents with ADHD were found to have:
- Marker for increased oxidative stress
- Antioxidants
- Paraoxonase-1 (PON-1) reduced in serum6
- Catalase in serum reduced8
- Superoxide dismutase reduced 7
- Melatonin
- Acts together with its metabolites as an indirect antioxidant10
- Elevated in serum in ADHD11
- Degradation substances in urine increased throughout the day in ADHD12
- Doubled on a daily average
- 2.5-fold increase during the day
- 1.5 times higher at night
- Melatonin higher in children with ADHD-HI1314
- MPH decreased melatonin metabolism in all ADHD subtypes1415
- But not the melatonin serum level15
- This is exciting in view of the fact that melatonin can cross the blood-brain barrier and the evening melatonin increase is supposed to promote sleep by eliminating light on the retina via a melatonin increase, while 75% of people with ADHD have a chronobiorhythm that is shifted backwards and at the same time melatonin as a spray has been shown to be very effective for sleep problems in ADHD.
- Markers of cellular immunity
- Adenosine deaminase (ADA) activity increased in serum6
SHR, an ADHD animal model, showed:16
- increased production of reactive oxygen species (ROS) in the cortex, striatum and hippocampus
- Reduced activity of glutathione peroxidase in PFC and hippocampus
2. Oxidative stress can increase neuroinflammation
In chronic oxidative stress, proteins and lipids oxidize and DNA is damaged. ROS can also lead to the activation of astrocytes and microglia. High ROS concentrations could activate a strong release of proinflammatory chemokines and cytokines and trigger a vicious circle between oxidative stress and neuroinflammation 17 1819
Neuroinflammation is considered a possible developmental pathway for ADHD.2021
3. ADHD medication reduces oxidative stress
MPH improved the redox profile in humans with reduced levels of advanced oxidation protein products, lipid peroxidation and nitrite plus nitrate (NOx) and increased activities of the ROS-degrading enzymes glutathione reductase and catalase.22
Single administration of MPH23
- increased ROS superoxide (hyperoxide) in young rats at both low and high doses in the cerebellum and only at high doses (10 mg/kg) also in the hippocampus
- did not affect superoxide in adult rats
Chronic administration (as is common as an ADHD medication)23 - did not affect superoxide in young rats
- decreased superoxide in the cerebellum of adult rats at lower doses
(Reduced) glutathione (GSH) is the most important intracellular antioxidant.
GSH protects against oxidative stress by balancing the production and degradation of ROS, whereby it oxidizes to GSSH. The enzyme glutathione reductase uses NADPH to convert GSSG back into two reduced GSH.
One study found increased levels of glutathione in erythrocytes in ADHD and that oxidative stress in ADHD is not triggered by food choices and that this increases neuroinflammation.9
Sezen H, Kandemir H, Savik E, Basmacı Kandemir S, Kilicaslan F, Bilinc H, Aksoy N (2016): Increased oxidative stress in children with attention deficit hyperactivity disorder. Redox Rep. 2016 Nov;21(6):248-53. doi: 10.1080/13510002.2015.1116729. PMID: 26886057; PMCID: PMC6837712. ↥ ↥
Abdulhameed EA, Al-Rawi NH, Omar M, Khalifa N, Samsudin ABR (2022): Titanium dioxide dental implants surfaces related oxidative stress in bone remodeling: a systematic review. PeerJ. 2022 Mar 3;10:e12951. doi: 10.7717/peerj.12951. PMID: 35261818; PMCID: PMC8898546. METASTUDY ↥
Cassera E, Ferrari E, Vignati DAL, Capucciati A (2025): The interaction between metals and catecholamines: oxidative stress, DNA damage, and implications for human health. Brain Res Bull. 2025 Apr 28;226:111366. doi: 10.1016/j.brainresbull.2025.111366. PMID: 40306586. REVIEW ↥
Kul M, Unal F, Kandemir H, Sarkarati B, Kilinc K, Kandemir SB (2015): Evaluation of Oxidative Metabolism in Child and Adolescent Patients with Attention Deficit Hyperactivity Disorder. Psychiatry Investig. 2015 Jul;12(3):361-6. doi: 10.4306/pi.2015.12.3.361. PMID: 26207130; PMCID: PMC4504919. ↥
Ceylan M, Sener S, Bayraktar AC, Kavutcu M (2010): Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1491-4. doi: 10.1016/j.pnpbp.2010.08.010. PMID: 20732373. ↥ ↥ ↥ ↥
Ceylan MF, Sener S, Bayraktar AC, Kavutcu M (2012): Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2012 Apr;66(3):220-6. doi: 10.1111/j.1440-1819.2012.02330.x. PMID: 22443244. n = 70 ↥ ↥ ↥ ↥
Selek S, Savas HA, Gergerlioglu HS, Bulut M, Yilmaz HR (2008): Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol. 2008 Oct;79(2):256-9. doi: 10.1016/j.biopsycho.2008.06.005. PMID: 18644422. n = 41 ↥ ↥
Nasim S, Naeini AA, Najafi M, Ghazvini M, Hassanzadeh A (2019): Relationship between Antioxidant Status and Attention Deficit Hyperactivity Disorder Among Children. Int J Prev Med. 2019 Apr 3;10:41. doi: 10.4103/ijpvm.IJPVM_80_18. PMID: 31057726; PMCID: PMC6484508. ↥ ↥ ↥
Verlaet AAJ, Breynaert A, Ceulemans B, De Bruyne T, Fransen E, Pieters L, Savelkoul HFJ, Hermans N (2019): Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison. Eur Child Adolesc Psychiatry. 2019 May;28(5):719-729. doi: 10.1007/s00787-018-1239-4. PMID: 30350094. ↥ ↥
Predescu E, Vaidean T, Rapciuc AM, Sipos R (2024): Metabolomic Markers in Attention-Deficit/Hyperactivity Disorder (ADHD) among Children and Adolescents-A Systematic Review. Int J Mol Sci. 2024 Apr 16;25(8):4385. doi: 10.3390/ijms25084385. PMID: 38673970; PMCID: PMC11050195. REVIEW ↥
Avcil, Uysal, Yenisey, Abas (2019): Elevated Melatonin Levels in Children With Attention Deficit Hyperactivity Disorder: Relationship to Oxidative and Nitrosative Stress. J Atten Disord. 2019 Feb 28:1087054719829816. doi: 10.1177/1087054719829816. n = 173 ↥
Büber A, Çakaloz B, Işıldar Y, Ünlü G, Bostancı HE, Aybek H, Herken H (2016): Increased urinary 6-hydroxymelatoninsulfate levels in attention deficit hyperactivity disorder diagnosed children and adolescent. Neurosci Lett. 2016 Mar 23;617:195-200. doi: 10.1016/j.neulet.2016.02.016. PMID: 26879834. ↥
Cubero-Millán I, Molina-Carballo A, Machado-Casas I, Fernández-López L, Martínez-Serrano S, Tortosa-Pinto P, Ruiz-López A, Luna-del-Castillo JD, Uberos J, Muñoz-Hoyos A (2014): Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes. Int J Mol Sci. 2014 Sep 25;15(9):17115-29. doi: 10.3390/ijms150917115. PMID: 25257531; PMCID: PMC4200748. ↥
Molina-Carballo A, Naranjo-Gómez A, Uberos J, Justicia-Martínez F, Ruiz-Ramos MJ, Cubero-Millán I, Contreras-Chova F, Augustin-Morales MD, Khaldy-Belkadi H, Muñoz-Hoyos A (2013): Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. J Psychiatr Res. 2013 Mar;47(3):377-83. doi: 10.1016/j.jpsychires.2012.09.020. PMID: 23088865. ↥ ↥
Cubero-Millán, Molina-Carballo, Machado-Casas, Fernández-López, Martínez-Serrano, Tortosa-Pinto, Ruiz-López, Luna-del-Castillo, Uberos, Muñoz-Hoyos (2014): Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes. Int J Mol Sci. 2014 Sep 25;15(9):17115-29. doi: 10.3390/ijms150917115. PMID: 25257531; PMCID: PMC4200748. n = 136 ↥ ↥
Leffa, Bellaver, de Oliveira, de Macedo, de Freitas, Grevet, Caumo, Rohde, Quincozes-Santos, Torres (2017): Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neurochem Res. 2017 Nov;42(11):3084-3092. doi: 10.1007/s11064-017-2341-6. ↥
Corona JC (2020): Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder. Antioxidants (Basel). 2020 Oct 23;9(11):1039. doi: 10.3390/antiox9111039. PMID: 33114154; PMCID: PMC7690797. REVIEW ↥
de Araújo Boleti AP, de Oliveira Flores TM, Moreno SE, Anjos LD, Mortari MR, Migliolo L (2020): Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochem Int. 2020 Jun;136:104714. doi: 10.1016/j.neuint.2020.104714. PMID: 32165170. REVIEW ↥
Solleiro-Villavicencio H, Rivas-Arancibia S (2018): Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases. Front Cell Neurosci. 2018 Apr 27;12:114. doi: 10.3389/fncel.2018.00114. PMID: 29755324; PMCID: PMC5934485. REVIEW ↥
Vázquez-González D, Carreón-Trujillo S, Alvarez-Arellano L, Abarca-Merlin DM, Domínguez-López P, Salazar-García M, Corona JC (2023): A Potential Role for Neuroinflammation in ADHD. Adv Exp Med Biol. 2023;1411:327-356. doi: 10.1007/978-981-19-7376-5_15. PMID: 36949317. REVIEW ↥
Dunn GA, Nigg JT, Sullivan EL (2019): Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav. 2019 Jul;182:22-34. doi: 10.1016/j.pbb.2019.05.005. PMID: 31103523; PMCID: PMC6855401. REVIEW ↥
Garre-Morata L, de Haro T, Villén RG, Fernández-López ML, Escames G, Molina-Carballo A, Acuña-Castroviejo D (2024): Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment. Antioxidants (Basel). 2024 Jan 12;13(1):92. doi: 10.3390/antiox13010092. PMID: 38247516; PMCID: PMC10812591. n = 59 ↥
Gomes KM, Inácio CG, Valvassori SS, Réus GZ, Boeck CR, Dal-Pizzol F, Quevedo J (2009): Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats. Neurosci Lett. 2009 Nov 6;465(1):95-8. doi: 10.1016/j.neulet.2009.08.060. PMID: 19716398. ↥ ↥